Regulations.gov document
2024-001770 - Beiture LLC - Beiture NR ResCo, Nicotinamide Riboside (NR) Resveratrol…
Other · FDA-2024-S-0024 · posted Dec 6, 2024
Key facts
| Document ID | FDA-2024-S-0024-0895 |
|---|---|
| Title | 2024-001770 - Beiture LLC - Beiture NR ResCo, Nicotinamide Riboside (NR) Resveratrol cocrystal - Defense Against Cellular Aging |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2024-S-0024 |
| Posted | Dec 6, 2024 |
| Comment period opens | Dec 6, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: